Ramaswamy Sridhar, Ross Ken N, Lander Eric S, Golub Todd R
Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USA.
Nat Genet. 2003 Jan;33(1):49-54. doi: 10.1038/ng1060. Epub 2002 Dec 9.
Metastasis is the principal event leading to death in individuals with cancer, yet its molecular basis is poorly understood. To explore the molecular differences between human primary tumors and metastases, we compared the gene-expression profiles of adenocarcinoma metastases of multiple tumor types to unmatched primary adenocarcinomas. We found a gene-expression signature that distinguished primary from metastatic adenocarcinomas. More notably, we found that a subset of primary tumors resembled metastatic tumors with respect to this gene-expression signature. We confirmed this finding by applying the expression signature to data on 279 primary solid tumors of diverse types. We found that solid tumors carrying the gene-expression signature were most likely to be associated with metastasis and poor clinical outcome (P < 0.03). These results suggest that the metastatic potential of human tumors is encoded in the bulk of a primary tumor, thus challenging the notion that metastases arise from rare cells within a primary tumor that have the ability to metastasize.
转移是导致癌症患者死亡的主要原因,但其分子基础却知之甚少。为了探究人类原发性肿瘤与转移瘤之间的分子差异,我们将多种肿瘤类型的腺癌转移灶与不匹配的原发性腺癌的基因表达谱进行了比较。我们发现了一种基因表达特征,可区分原发性腺癌和转移性腺癌。更值得注意的是,我们发现一部分原发性肿瘤在该基因表达特征方面类似于转移性肿瘤。我们通过将该表达特征应用于279种不同类型原发性实体瘤的数据来证实了这一发现。我们发现具有该基因表达特征的实体瘤最有可能与转移和不良临床结局相关(P < 0.03)。这些结果表明,人类肿瘤的转移潜能在原发性肿瘤主体中编码,从而挑战了转移瘤源自原发性肿瘤内具有转移能力的罕见细胞这一观念。